Cancer research over past decades has revealed a complex biological landscape driven by dynamic genetic alterations within tumor cell genomes. Authors Douglas Hanahan and Robert A. Weinberg propose a conceptual framework that codifies these complexities into a small set of underlying cellular principles shared by most human cancers. By synthesizing extensive molecular, biochemical, and cellular evidence, the authors identify six essential acquired capabilities: self-sufficiency in growth signals, insensitivity to antigrowth signals, evasion of apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis. These physiological traits represent the successful breaching of cellular defense mechanisms and are facilitated by genome instability as an enabling characteristic. The paper also highlights that tumors function as complex heterotypic tissues where malignant cells subvert stromal and inflammatory cells to collaborate in neoplastic growth. Ultimately, this framework shifts cancer biology toward a logical science, paving the way for targeted therapeutic strategies against hallmark capabilities.
Key Takeaways
Human tumor development is a multistep evolutionary process driven by 4 to 7 rate-limiting stochastic genetic alterations.
Functional inactivation of the p53 tumor suppressor protein occurs in greater than 50% of human cancers, disabling a primary DNA damage sensor and apoptotic pathway.
Limitless replicative potential requires telomere maintenance, which is achieved through telomerase enzyme upregulation in 85% to 90% of human malignant cells.
Tissue invasion and distant metastases are responsible for 90% of human cancer deaths and involve functional loss of E-cadherin cell-cell adhesion.
Pro-angiogenic factors like VEGF and countervailing inhibitors like thrombospondin-1 govern the angiogenic switch required for macroscopic tumor growth beyond 100 µm from blood vessels.
Structurally altered Ras proteins trigger continuous mitogenic signals in approximately 25% of all human tumors and nearly 50% of colon carcinomas.
Learning Objectives
Identify the six essential acquired capabilities that govern malignant transformation in human cancers.
Explain the molecular mechanisms by which cancer cells evade apoptosis and achieve limitless replicative potential.
Describe the role of heterotypic signaling between malignant cells and stromal components within the tumor microenvironment.
Differentiate between core hallmark capabilities and enabling characteristics like genomic instability.
Glossary
Oncogene
A gene whose dominant gain-of-function mutation or overexpression drives excessive cell proliferation and tumor development.
Tumor Suppressor Gene
A gene whose recessive loss-of-function mutation eliminates growth-inhibitory or pro-apoptotic controls, facilitating tumorigenesis.
Apoptosis
A programmed sequence of cell death executed by intracellular caspases in response to physiological or cellular stress signals.
Telomerase
A specialized enzyme that adds hexanucleotide repeats to chromosomal ends, maintaining telomeres and enabling cellular immortalization.
Angiogenesis
The process of sprouting new capillary blood vessels from existing vasculature to supply oxygen and nutrients to tissues.
Heterotypic Signaling
Intercellular communication between distinct cell types in a tissue, such as signals exchanged between tumor cells and surrounding stromal cells.
E-cadherin
A homotypic cell-to-cell adhesion molecule whose functional inactivation releases cells from structural tethering, promoting invasion and metastasis.
Timeline
1954Foulds establishes that tumor development proceeds progressively from normalcy to malignancy via multiple distinct steps.
1972Kerr, Wyllie, and Currie describe massive apoptosis in hormone-dependent tumor cells following hormone withdrawal.
1976Nowell formulates the model of clonal evolution of tumor cell populations driven by successive genetic alterations.
1993Renan analyzes age-dependent cancer incidence data implicating four to seven rate-limiting stochastic events in human carcinogenesis.
Mind Map
Everything is expanded by default. Use the − buttons to collapse a branch, or the controls below.
Hallmarks of Cancer
Self-Sufficiency in Growth Signals
Insensitivity to Antigrowth Signals
Evading Apoptosis
Limitless Replicative Potential
Sustained Angiogenesis
Tissue Invasion and Metastasis
Genome Instability
Heterotypic Microenvironment
The Six Hallmarks of Cancer Cell Biology
Essential acquired physiological traits shared across human malignancies
skull
90%
Cancer deaths caused by tissue invasion and metastasis
infinity
85%–90%
Malignancies upregulating telomerase for immortalization
shield-alert
>50%
Human cancers with functional p53 inactivation
activity
25%
Human tumors harboring structurally altered Ras proteins
heart
100 µm
Maximum distance of cells from capillary vessels
layers
4–7
Stochastic rate-limiting events in human tumorigenesis
Heterotypic Tumor Microenvironment
Tumors operate as complex tissues where malignant cells conscript and subvert normal stromal cells to serve their growth agenda.
The Angiogenic Switch
Neovascularization is triggered when the balance shifts from endogenous inhibitors like thrombospondin-1 toward inducers like VEGF.
Genomic Instability as an Enabler
Defects in DNA monitoring and repair caretaker systems increase mutability to allow the acquisition of hallmark traits.
Why is cancer described as a multistep evolutionary process?
Tumor development mirrors Darwinian evolution, where normal cells undergo a succession of genetic alterations—typically 4 to 7 stochastic rate-limiting events—that confer progressive selective growth advantages, converting normal cells into invasive cancers.
How do cancer cells acquire growth signal autonomy?
Cancer cells achieve self-sufficiency in growth signals by synthesizing their own growth factors (autocrine stimulation), overexpressing or altering cell surface receptors (like EGF-R/HER2), or mutating downstream signaling components like Ras.
What is the distinction between hallmark capabilities and enabling characteristics?
Hallmark capabilities are the six functional biological endpoints acquired during tumor development (e.g. sustained angiogenesis, evading apoptosis). Enabling characteristics, such as genomic instability, represent the mutational means that allow evolving cells to reach these endpoints.
How does the tumor microenvironment contribute to cancer progression?
Tumors are complex heterotypic tissues containing malignant cells alongside normal stromal fibroblasts, endothelial cells, and immune cells. Cancer cells co-opt these normal cells through paracrine signaling to obtain growth factors, proteases, and blood vessel support.
References
Hanahan, D., and Weinberg, R.A. (2000). The Hallmarks of Cancer. Cell 100, 57–70.
Foulds, L. (1954). The Experimental Study of Tumor Progression. Academic Press.
Kinzler, K.W., and Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell 87, 159–170.
Kerr, J.F., Wyllie, A.H., and Currie, A.R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239–257.